Comparing the effects of MSCs and CD34+ cell therapy in a rat model of myocardial infarction

IUBMB Life

Volumn 68, Issue 5, 2016, Pages 343-354

  Shalaby, Sally M ^a   El Shal, Amal S ^a   Zidan, Haidy E ^a   Mazen, Nehad F ^a   Abd El Haleem, Manal R ^a   Abd El Motteleb, Dalia M ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

animal models; CD34+ cells; human umbilical cord blood; MSCs; myocardial infarction

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; CD133 ANTIGEN; CD34 ANTIGEN; EOSIN; HEMATOXYLIN; HERMES ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ANGIOGENIC PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; T WAVE; TISSUE REGENERATION; UMBILICAL CORD BLOOD; UPREGULATION; ANIMAL; CARDIAC MUSCLE; CYTOLOGY; DISEASE MODEL; FETUS BLOOD; HEART CONTRACTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ANGIOGENIC PROTEINS; ANIMALS; ANTIGENS, CD34; DISEASE MODELS, ANIMAL; FETAL BLOOD; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RATS, WISTAR;

EID: 84960146096     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1487     Document Type: Article

References (43)

1. Nabel, E. G., and, Braunwald, E., (2012) A tale of coronary artery disease and myocardial infarction. N. Engl. J. Med. 366, 54-63.
2. Mitsos, S., Katsanos, K., Koletsis, E., Kagadis, G. C., Anastasiou, N., et al., (2012) Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials. Angiogenesis 15, 1-22.
3. Ranganath, S. H., Levy, O., Inamdar, M. S., and, Karp, J. M., (2012) Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10, 244-258.
4. Butler, M. G., and, Menitove, J. E., (2011) Umbilical cord blood banking: an update. J. Assist. Reprod. Genet. 28, 669-676.
5. McKenna, D., and, Sheth, J., (2011) Umbilical cord blood: current status & promise for the future. Indian J. Med. Res. 134, 261-269.
6. Lee, M. W., Jang, I. K., Yoo, K. H., Sung, K. W., and, Koo, H. H., (2010) Stem and progenitor cells in human umbilical cord blood. Int. J. Hematol. 92, 45-51.
7. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., et al., (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317.
8. Secco, M., Zucconi, E., Vieira, N. M., Fogaça, L. Q., Cerqueira, A., et al., (2008) Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells 26, 146-150.
9. Goodwin, H. S., Bicknese, A. R., Chien, S. N., Bogucki, B. D., Quinn, C. O., et al., (2001) Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat and neural markers. Biol. Blood Marrow Transplant. 7, 581-588.
10. Abdelwahid, E., Siminiak, T., Guarita-Souza, L. C., Teixeira de Carvalho, K. A., Gallo, P., et al., (2011) Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications. Curr. Cardiol. Rev. 7, 201-212.
11. Mackie, A. R., and, Losordo, D. W., (2011) CD34-positive stem cells: in the treatment of heart and vascular disease in human beings. Tex. Heart Inst. J. 38, 474-485.
12. Sun, Q., Zhang, Z., and, Sun, Z., (2014) The potential and challenges of using stem cells for cardiovascular repair and regeneration. Genes Dis. 1, 113-119.
13. van den Borne, S. W., Diez, J., Blankesteijn, W. M., Verjans, J., Hofstra, L., et al., (2010) Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 7, 30-37.
14. Carmeliet, P., (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395.
15. Kawamoto, A., Tkebuchava, T., Yamaguchi, J., Nishimura, H., Yoon, Y. S., et al., (2003) Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107, 461-468.
16. Tang, J., Xie, Q., Pan, G., Wang, J., and, Wang, M., (2006) Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Eur. J. Cardiothorac. Surg. 30, 353-361.
17. Wang, J., Zhang, S., Rabinovich, B., Bidaut, L., Soghomonyan, S., et al., (2010) Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ. Res. 106, 1904-1911.
18. Cébe-Suarez, S., Zehnder-Fjällman, A., and, Ballmer-Hofer, K., (2006) The role of VEGF receptors in angiogenesis; complex partnerships. Cell. Mol. Life Sci. 63, 601-615.
19. Martin, V., Liu, D., Fueyo, J., and, Gomez-Manzano, C., (2008) Tie2: a journey from normal angiogenesis to cancer and beyond. Histol. Histopathol. 23, 773-780.
20. Fagiani, E., and, Christofori, G., (2013) Angiopoietins in angiogenesis. Cancer Lett. 328, 18-26.
21. Bieback, K., Kern, S., Kluter, H., and, Eichler, H., (2004) Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22, 625-634.
22. Lee, T. M., Lin, M. S., and, Chang, N. C., (2008) Effect of ATP-sensitive potassium channel agonists on ventricular remodeling in healed rat infarcts. J. Am. Coll. Cardiol. 51, 1309-1318.
23. Jiang, C. Y., Gui, C., He, A. N., Hu, X. Y., Chen, J., et al., (2008) Optimal time for mesenchymal stem cell transplantation in rats with myocardial infarction. J. Zhejiang Univ. Sci. B 9, 630-637.
24. Gay, W. I., (1965) Methods of Animal Experimentation, Vol. 1-7. Academic Press, New York.
25. Frantz, S., Calvillo, L., Tillmanns, J., Elbing, I., Dienesch, C., et al., (2005) Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the α-glucosidase inhibitor acarbose. FASEB J. 19, 591-593.
26. Bancroft, J. D., and, Gamble, M., (2008) Theory and Practice of Histological Techniques, 6th edn. Churchill Livingstone, New York. p. 165e75.
27. Ramos-Vara, J. A., Kiupel, M., Baszier, T., Bliven, L., Brodersen, B., et al., (2008) Suggested guidelines for immunohistochemical techniques in veterinary diagnostic laboratories. J. Vet. Diagn. Invest. 20, 393-413.
28. Copeland, N., Harris, D., and, Gaballa, M. A., (2009) Human umbilical cord blood stem cells, myocardial infarction and stroke. Clin. Med. 9, 342-345.
29. Acosta, S. A., Franzese, N., Staples, M., Weinbren, N. L., Babilonia, M., et al., (2013) Human umbilical cord blood for transplantation therapy in myocardial infarction. J. Stem Cell Res. Ther. 1, pii S4-005.
30. Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., et al., (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7, 430-436.
31. Kawamoto, A., Iwasaki, H., Kusano, K., Murayama, T., Oyamada, A., et al., (2006) CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 114, 2163-2169.
32. van der Spoel, T. I., Jansen of Lorkeers, S. J., Agostoni, P., van Belle, E., Gyöngyösi, M., et al., (2011) Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. Cardiovasc. Res. 91, 649-658.
33. Tao, B., Cui, M., Wang, C., Ma, S., Wu, F., et al., (2015) Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart. Theranostics 5, 196-205.
34. Bronckaers, A., Hilkens, P., Martens, W., Gervois, P., Ratajczak, J., et al., (2014) Mesenchymal stem/stromal cells as pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacol. Ther. 143, 181-196.
35. Miyahara, Y., Nagaya, N., Kataoka, M., Yanagawa, B., Tanaka, K., et al., (2006) Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 12, 459-465.
36. Kim, S. W., Zhang, H. Z., Kim, C. E., Kim, J. M., and, Kim, M. H., (2013) Amniotic mesenchymal stem cells with robust chemotactic properties are effective in the treatment of a myocardial infarction model. Int. J. Cardiol. 168, 1062-1069.
37. Shabbir, A., Zisa, D., Lin, H., Mastri, M., Roloff, G., et al., (2010) Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair. Am. J. Physiol. Heart Circ. Physiol. 299, H1428-H1438.
38. Yoshioka, T., Ageyama, N., Shibata, H., Yasu, T., Misawa, Y., et al., (2005) Repair of infarcted myocardium mediated by transplanted bone marrow-derived CD34+ stem cells in a nonhuman primate model. Stem Cells 23, 355-364.
39. Rahbarghazi, R., Nassiri, S. M., Khazraiinia, P., Kajbafzadeh, A. M., Ahmadi, et al., (2013) Juxtacrine and paracrine interactions of rat marrow-derived mesenchymal stem cells, muscle-derived satellite cells, and neonatal cardiomyocytes with endothelial cells in angiogenesis dynamics. Stem Cells Dev. 22, 855-865.
40. Rahbarghazi, R., Nassiri, S. M., Ahmadi, S. H., Mohammadi, E., Rabbani, S., et al., (2014) Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction. Int. J. Cardiol. 173, 453-466.
41. Santos Nascimento, D., Mosqueira, D., Sousa, L. M., Teixeira, M., Filipe, M., et al., (2014) Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms. Stem Cell Res. Ther. 5, 5.
42. Locatelli, P., Olea, F. D., Hnatiuk, A., De Lorenzi, A., Cerdá, M., et al., (2015) Mesenchymal stromal cells overexpressing vascular endothelial growth factor in ovine myocardial infarction. Gene Ther. 22, 449-457.
43. de Jong, R., Houtgraaf, J. H., Samiei, S., Boersma, E., and, Duckers, H. J., (2014) Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Circ. Cardiovasc. Interv. 7, 156-167.